PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today commented on a recent Bloomberg News story, Drugmakers Failing More Plant Inspections Under Obama’s FDA, in which a number of drug manufacturing companies, including Lannett, are mentioned as having failed a high number of inspections by FDA inspectors from fiscal 2000 through the year ended Sept. 30, 2010.
